The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Hyperuricemia and risk of stroke: A systematic review and meta‐analysis
Open accessAbstract
Objective: To assess the association between hyperuricemia and risk of stroke incidence and mortality because hyperuricemia is hypothesized to be a risk factor for stroke and other cardiovascular disease, but, to date, results from observational studies are conflicting. Methods: A systematic review and meta‐analysis were conducted. Studies were identified by searching major electronic databases using the Medical Subject Headings and keywords without restriction in languages. Prospective cohort studies were included only if they contained data on stroke incidences or mortalities related to serum uric acid levels in adults. Pooled risk ratios (RRs) for the association of stroke incidence and mortality with serum uric acid levels were calculated. Results: A total of 16 studies including 238,449 adults were eligible and abstracted. Hyperuricemia was associated with a significantly higher risk of both stroke incidence (6 studies; RR 1.41, 95% confidence interval [95% CI] 1.05, 1.76) and mortality (6 studies; RR 1.36, 95% CI 1.03, 1.69) in our meta‐analyses of unadjusted study estimates. Subgroup analyses of studies adjusting for known risk factors such as age, hypertension, diabetes mellitus, and cholesterol still showed that hyperuricemia was significantly associated with both stroke incidence (4 studies; RR 1.47, 95% CI 1.19, 1.76) and mortality (6 studies; RR 1.26, 95% CI 1.12, 1.39). The pooled estimate of multivariate RRs did not differ significantly by sex. Conclusion: Hyperuricemia may modestly increase the risks of both stroke incidence and mortality. Future research is needed to determine whether lowering uric acid level has any beneficial effects on stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“[Statement]Hyperuricemia can be regarded as a risk factor for ASCVD. (Evidence level: E2)”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [206]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Heart Disease and Stroke Statistics—2008 Update
Writing Group Members, Rosamond, W. D., Flegal, K. M., Furie, K. L., Go, A. S., Greenlund, K. J., Haase, N., Hailpern, S. M., Ho, M., Howard, V. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,799
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,467
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Serum Uric Acid and Cardiovascular Mortality
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,516
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
Cited by
Sorted by citations
Uric acid transport and disease
So, A. K.-L., & Thorens, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42344 · Cited by 879
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis
Kim, S. Y., Guevara, J. P., Kim, K. M., Choi, H. K., Heitjan, D. F., & Albert, D. A. (2010) · Arthritis Care & Research · doi:10.1002/acr.20065 · Cited by 671
Self-citationYanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179221 · Cited by 635
High plasma uric acid concentration: causes and consequences
de Oliveira, E. P., & Burini, R. C. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-12 · Cited by 502
Uric acid and cardiovascular disease
Ndrepepa, G. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.046 · Cited by 512
Gout epidemiology and comorbidities
Singh, J. A., & Gaffo, A. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.04.008 · Cited by 505
The role of uric acid in the pathogenesis of human cardiovascular disease
Kanbay, M., Segal, M. S., Afşar, B., Kang, D., Rodríguez‐Iturbe, B., & Johnson, R. J. (2013) · Heart · doi:10.1136/heartjnl-2012-302535 · Cited by 458
Uric acid, hyperuricemia and vascular diseases
Jin, M. J. (2011) · Frontiers in bioscience · doi:10.2741/3950 · Cited by 422
Li, X., Meng, X., Timofeeva, M. N., Tzoulaki, I., Tsilidis, K. K., Ioannidis, J. P. A., Campbell, H. J., & Τheodoratou, E. (2017) · BMJ · doi:10.1136/bmj.j2376 · Cited by 402
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
Bardin, T., & Richette, P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0890-9 · Cited by 387
Physiology of Hyperuricemia and Urate-Lowering Treatments
Benn, C., Dua, P., Gurrell, R., Loudon, P. T., Pike, A. J., Storer, R. I., & Vangjeli, C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00160 · Cited by 339
Uric Acid and Cardiovascular Events
Kleber, M. E., Delgado, G., Grammer, T. B., Silbernagel, G., Huang, J., Krämer, B. K., Ritz, E., & März, W. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070660 · Cited by 302
Palmer, T. M., Nordestgaard, B. G., Benn, M., Tybjaerg-Hansen, A., Davey Smith, G., Lawlor, D. A., & Timpson, N. J. (2013) · BMJ · doi:10.1136/bmj.f4262 · Cited by 282
Zhao, G., Huang, L. J., Song, M., & Song, Y. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.023 · Cited by 281
Soltani, Z., Rasheed, K., Kapusta, D. R., & Reisin, E. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0344-5 · Cited by 271
Kanbay, M., Huddam, B., Azak, A., Solak, Y., Kadioglu, G. K., Kirbas, I., Duranay, M., Covic, A. C., & Johnson, R. J. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11451210 · Cited by 248
Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome
Chaudhary, K. R., Malhotra, K., Sowers, J. R., & Aroor, A. R. (2013) · Cardiorenal Medicine · doi:10.1159/000355405 · Cited by 242
Is it time to revise the normal range of serum uric acid levels?
Desideri, G., Castaldo, G., Lombardi, A., Mussap, M., Testa, A., Pontremoli, R., Punzi, L., & Borghi, C. (2014) · PubMed · Cited by 232
Improving cardiovascular and renal outcomes in gout: what should we target?
Richette, P., Pérez-Ruiz, F., Doherty, M., Jansen, T., Nuki, G., Pascual, E., Punzi, L., So, A. K.-L., & Bardin, T. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.124 · Cited by 228
Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies
Li, M., Hou, W.-S., Zhang, X., Hu, L., & Tang, Z. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.051 · Cited by 223
Gustafsson, D., & Unwin, R. J. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-164 · Cited by 212
Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China
Song, P., Wang, H., Xia, W., Chang, X., Wang, M., & An, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-22570-9 · Cited by 198
Epidemiology of gout: An update
Smith, E. U. R., Díaz‐Torné, C., Pérez-Ruiz, F., & MARCH, L. M. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2010.10.004 · Cited by 184
Keenan, T. E., Zhao, W., Rasheed, A., Ho, W.-K., Malik, R., Felix, J. F., Young, R., Shah, N., Samuel, M., Sheikh, N., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.086 · Cited by 187
A Prospective Controlled Study of Living Kidney Donors: Three-Year Follow-up
Kasiske, B. L., Anderson-Haag, T. L., Israni, A. K., Kalil, R. S., Kimmel, P. L., Kraus, E. S., Kumar, R., Posselt, A. M., Pesavento, T. E., Rabb, H., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.019 · Cited by 182
Multidisciplinary Expert Task Force on Hyperuricemia and Related Diseases (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.216416 · Cited by 163
Vera, M. A. D., Rahman, M., Bhole, V., Kopec, J. A., & Choi, H. K. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122770 · Cited by 154
Self-citationThe Epidemiology of Uric Acid and Fructose
Rho, Y. H., Zhu, Y., & Choi, H. K. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.004 · Cited by 156
Self-citationNabipour, I., Sambrook, P. N., Blyth, F., Janu, M. R., Waite, L. M., Naganathan, V., Handelsman, D. J., Couteur, D. G. L., Cumming, R. G., & Seibel, M. J. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.286 · Cited by 152
Sattui, S. E., & Gaffo, A. (2016) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x16646703 · Cited by 153
Solomon, D. H., Liu, C., Kuo, I.-H., Zak, A., & Kim, S. C. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207984 · Cited by 152
Self-citationAssociation of Hyperuricemia with Renal Outcomes, Cardiovascular Disease, and Mortality
Liu, W., Hung, C., Chen, S., Yeh, S.-M., Lin, M., Chiu, Y., Kuo, M., Chang, J., Hwang, S., & Chen, H. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09420911 · Cited by 142
Hypertension in children: new trends and challenges
Feber, J., & Ahmed, M. (2010) · Clinical Science · doi:10.1042/cs20090544 · Cited by 141
Chuang, S., Lee, S.-C., Hsieh, Y.-T., & Pan, W. (2011) · PubMed · Cited by 140
Storhaug, H. M., Norvik, J. V., Toft, I., Eriksen, B. O., Løchen, M., Zykova, S. N., Solbu, M. D., White, S., Chadban, S. J., & Jenssen, T. G. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-115 · Cited by 137
Is there anything good in uric acid?
Alvarez‐Lario, B., & Macarrón‐Vicente, J. (2011) · QJM · doi:10.1093/qjmed/hcr159 · Cited by 137
van Holten, T. C., Waanders, L. F., de Groot, P. G., Vissers, J. L. M., Hoefer, I. E., Pasterkamp, G., Prins, M. W. J., & Roest, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062080 · Cited by 130
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy
Liu, N., Wang, L., Yang, T., Xiong, C., Xu, L., Shi, Y., Bao, W., Chin, Y. E., Cheng, S., Yan, H., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014080793 · Cited by 128
Serum Uric Acid and Mortality Form Cardiovascular Disease: EPOCH-JAPAN Study
Zhang, W., Iso, H., Murakami, Y., Miura, K., Nagai, M., Sugiyama, D., Ueshima, H., Okamura, T., & EPOCH-JAPAN GROUP (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31591 · Cited by 127
Clarson, L. E., Hider, S., Belcher, J., Heneghan, C. J., Roddy, E., & Mallen, C. D. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205252 · Cited by 132
Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care
Choi, H. K., McCormick, N., & Yokose, C. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00725-9 · Cited by 125
Self-citationHyperuricemia is an independent competing risk factor for atrial fibrillation
Kuwabara, M., Niwa, K., Nishihara, S., Nishi, Y., Takahashi, O., Kario, K., Yamamoto, K., Yamashita, T., & Hisatome, I. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.268 · Cited by 115
Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke
Wang, Z., Lin, Y., Liu, Y., Chen, Y., Wang, B., Li, C., Yan, S., Wang, Y., & Zhao, W. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9134-1 · Cited by 113
Woodward, O. M., Tukaye, D. N., Cui, J., Greenwell, P., Constantoulakis, L. M., Parker, B. S., Rao, A., Köttgen, M., Maloney, P. C., & Guggino, W. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214530110 · Cited by 114
Wang, R., Song, Y., Yan, Y., & Ding, Z. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.006 · Cited by 108
Gout and its comorbidities: implications for therapy
Stamp, L. K., & Chapman, P. T. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes211 · Cited by 107
Ito, H., Abe, M., Mifune, M., Oshikiri, K., Antoku, S., Takeuchi, Y., & Togane, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027817 · Cited by 106
Fleischmann, R., Kerr, B. M., Yeh, L., Suster, M., Shen, Z., Polvent, E., Hingorani, V. N., Quart, B. D., Manhard, K. J., Miner, J. N., et al. (2014) · Rheumatology · doi:10.1093/rheumatology/ket487 · Cited by 102
Allopurinol as a therapeutic option in cardiovascular disease
Okafor, O., Farrington, K., & Gorog, D. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.12.004 · Cited by 102
Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort study
U., A. K. A., Browne, L., Li, X., Adeeb, F., Pérez-Ruiz, F., Fraser, A. D., & Stack, A. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198197 · Cited by 100
Serum Urate and the Risk of Parkinson's Disease: Results From a Meta-Analysis
Shen, C., Guo, Y. C., Luo, W. F., Chen, L., & Ding, M. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012981 · Cited by 100
Wen, C. P., Cheng, T. D., Chan, H. T., Tsai, M. K., Chung, W.-S. I., Tsai, S. P., Wahlqvist, M. L., Yang, Y. C., Wu, S. B., Chiang, P. H., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.01.024 · Cited by 94
Kim, S. C., Newcomb, C. W., Margolis, D. J., Roy, J., & Hennessy, S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21817 · Cited by 90
Self-citationKim, S. C., Schneeweiß, S., Choudhry, N. K., Liu, J., Glynn, R. J., & Solomon, D. H. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.01.013 · Cited by 86
Self-citationBorghi, C., Domienik‐Karłowicz, J., Tykarski, A., Widecka, K., Filipiak, K. J., Jaguszewski, M. J., Narkiewicz, K., & Mancia, G. (2021) · Cardiology Journal · doi:10.5603/cj.a2021.0001 · Cited by 93
Teng, G. G., Ang, L. W., Saag, K. G., Yu, M. C., Yuan, J., & Koh, W. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.200523 · Cited by 87
Keenan, T. E., Blaha, M. J., Nasir, K., Silverman, M. G., Tota-Maharaj, R., Carvalho, J. A. M., Conceição, R., Blumenthal, R. S., & Santos, R. D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.012 · Cited by 85
Relationships Among Hyperuricemia, Metabolic Syndrome, and Endothelial Function
Tomiyama, H., Higashi, Y., Takase, B., Node, K., Sata, M., Inoue, T., Ishibashi, Y., Ueda, S., Shimada, K., & Yamashina, A. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.55 · Cited by 84
Zhong, C., Zhong, X., Xu, T., Xu, T., & Zhang, Y. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005042 · Cited by 82
Association between serum uric acid levels and mortality: a nationwide community-based cohort study
Konta, T., Ichikawa, K., Kawasaki, R., Fujimoto, S., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., Narita, I., Kondo, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63134-0 · Cited by 84
Kanbay, M., Sánchez‐Lozada, L. G., Franco, M., Madero, M., Solak, Y., Rodríguez‐Iturbe, B., Covic, A. C., & Johnson, R. J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq635 · Cited by 81
Uric acid induced inflammatory responses in endothelial cells via up-regulating(pro)renin receptor
Yang, X., Gu, J., Lv, H., Li, H., Cheng, Y., Liu, Y., & Jiang, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.129 · Cited by 79
2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia
Hamburger, M. I., Baraf, H. S. B., Adamson, T. C., Basile, J., Bass, L., Cole, B., Doghramji, P. P., Guadagnoli, G. A., Hamburger, F., Harford, R., et al. (2011) · The Physician and Sportsmedicine · doi:10.3810/psm.2011.11.1946 · Cited by 76
Lane, N. E., Parimi, N., Lui, L., Wise, B. L., Yao, W., Lay, Y.-A. E., Cawthon, P. M., ORWOLL, E. S., & for the Osteoporotic Fractures in Men (MrOS) Study Group (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2164 · Cited by 78
A Prospective Controlled Study of Kidney Donors: Baseline and 6-Month Follow-up
Kasiske, B. L., Anderson-Haag, T. L., Ibrahim, H. N., Pesavento, T. E., Weir, M. R., Nogueira, J. M., Cosio, F. G., Kraus, E. S., Rabb, H., Kalil, R. S., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.01.027 · Cited by 77
Association between endothelial dysfunction and hyperuricaemia
Ho, W.-J., Tsai, W., Yu, K., Tsay, P., Wang, C.-L., Hsu, T. S., & Kuo, C.-T. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq184 · Cited by 78
Katsiki, N., Karagiannis, A. I., Athyros, V. G., & Mikhailidis, D. P. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283595adc · Cited by 78
Alcohol intake and the risk of hyperuricaemia: A 6-year prospective study in Japanese men
Nakamura, K., Sakurai, M., Miura, K., Morikawa, Y., Yoshita, K., Ishizaki, M., Kido, T., Naruse, Y., Suwazono, Y., & Nakagawa, H. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.01.003 · Cited by 73
Adherence to the Mediterranean diet and serum uric acid: the ATTICA study
Kontogianni, M. D., Chrysohoou, C. A., Panagiotakos, D., Tsetsekou, E., Zeimbekis, A., Pitsavos, C. E., & Stefanadis, C. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2012.679964 · Cited by 74
Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study
Larsen, K. S., Pottegård, A., Lindegaard, H., & Hallas, J. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.11.003 · Cited by 73
Dong, H., Xu, Y., Zhang, X., & Tian, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09455-z · Cited by 73
Serum Uric Acid Independently Predicts Cardiovascular Events in Advanced Nephropathy
Kanbay, M., Yılmaz, M. İ., Sönmez, A., Solak, Y., Sağlam, M., Çakır, E., Ünal, H. U., Arslan, E., Verim, S., Madero, M., et al. (2012) · American Journal of Nephrology · doi:10.1159/000342390 · Cited by 70
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
Korczowska-Łącka, I., Słowikowski, B. K., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., Permoda-Pachuta, A., & Dorszewska, J. (2023) · Antioxidants · doi:10.3390/antiox12101811 · Cited by 84
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
Singh, J. A., Ramachandaran, R., Yu, S., & Curtis, J. R. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0513-6 · Cited by 68
Godin, O., Leboyer, M., Gaman, A., Aouizerate, B., Berna, F. S., Brunel, L., Capdevielle, D., Chéreau, I., Dorey, J., Dubertret, C., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.047 · Cited by 69
Yu, S., Chen, Y., Hou, X., Xu, D., Che, K., Li, C., Yan, S., Wang, Y., & Wang, B. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9075-0 · Cited by 67
Serum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER Study
Chiquete, E., Ruíz‐Sandoval, J. L., Murillo-Bonilla, L. M., Araúz, A., Orozco-Valera, D. R., Ochoa-Guzmán, A., Villarreal-Careaga, J., León-Jiménez, C., Barinagarrementería, F., Ramos-Moreno, A., et al. (2013) · Cerebrovascular Diseases · doi:10.1159/000346603 · Cited by 66
Botson, J. K., Tesser, J., Bennett, R., Kenney, H. M., Peloso, P. M. J., Obermeyer, K. L., LaMoreaux, B. D., Weinblatt, M. E., & Peterson, J. R. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200460 · Cited by 64
Investigational drugs for hyperuricemia
Shahid, H., & Singh, J. A. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1051617 · Cited by 65
Krishnan, E. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000157 · Cited by 63
Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
Stamp, L. K., & Dalbeth, N. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.07.015 · Cited by 65
Cox, P. J., Gupta, S. O., Zhao, S. S., & Hughes, D. M. (2021) · Rheumatology International · doi:10.1007/s00296-021-04876-6 · Cited by 62
Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications
Timsans, J., Palomäki, A., & Kauppi, M. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247616 · Cited by 62
Relationship between Uric Acid and Subtle Cognitive Dysfunction in Chronic Kidney Disease
Afşar, B., Elsürer, R., Covic, A. C., Johnson, R. J., & Kanbay, M. (2011) · American Journal of Nephrology · doi:10.1159/000329097 · Cited by 64
Hyperuricemia and cardiovascular disease risk
Borghi, C., Verardi, F. M., Pareo, I., Bentivenga, C., & Cicero, A. F. G. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.957675 · Cited by 63
Kırça, M., Oğuz, N., Çetin, A., Uzuner, F., & Yeşilkaya, A. (2016) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2016.1203941 · Cited by 62
Association of Visceral Fat and Liver Fat With Hyperuricemia
Yamada, A., Satō, K., Kinuhata, S., Uehara, S., Endo, G., Hikita, Y., Fujimoto, W. Y., Boyko, E. J., & Hayashi, T. (2015) · Arthritis Care & Research · doi:10.1002/acr.22729 · Cited by 62
Uric acid and neurological disease: a narrative review
Otani, N., Hoshiyama, E., Ouchi, M., Takekawa, H., & Suzuki, K. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1164756 · Cited by 58
Kawai, T., Ohishi, M., Takeya, Y., Onishi, M., Ito, N., Yamamoto, K. I., Kamide, K., & Rakugi, H. (2012) · Hypertension Research · doi:10.1038/hr.2012.99 · Cited by 61
Disveld, I. J. M., Zoakman, S., Jansen, T., Rongen, G. A. P. J. M., Kienhorst, L. B. E., Janssen, M., Fransen, J., & Janssen, M. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04520-6 · Cited by 59
Mao, T., He, Q., Yang, J., Jia, L., & Xu, G. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01268-1 · Cited by 58
Chaudhary, N. S., Bridges, S. L., Saag, K. G., Rahn, E. J., Curtis, J. R., Gaffo, A., Limdi, N. A., Levitan, E. B., Singh, J. A., Colantonio, L. D., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13580 · Cited by 58
Mendelian Randomization: Application to Cardiovascular Disease
Timpson, N. J., Wade, K. H., & Smith, G. D. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0242-7 · Cited by 60
Clinical utility of dual-energy CT for gout diagnosis
Hu, H., Liao, M., & Xu, L. (2015) · Clinical Imaging · doi:10.1016/j.clinimag.2014.12.015 · Cited by 55
Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis
Luo, Q., Xia, X., Li, B., Lin, Z., Yu, X., & Huang, F. (2019) · BMC Nephrology · doi:10.1186/s12882-018-1143-7 · Cited by 55
Chao, T., Liu, C., Chen, S., Wang, K.-L., Lin, Y.-J., Chang, S., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Chen, T.-J., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.011 · Cited by 53
Kamei, K., Konta, T., Hirayama, A., Ichikawa, K., Kubota, I., Fujimoto, S., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., et al. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1311-7 · Cited by 53
Tang, L., Xu, Y., Wei, Y., & He, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7405 · Cited by 57
Hyperuricemia and Gout: New Concepts in Diagnosis and Management
Doghramji, P. P., & Wortmann, R. L. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.11.2616 · Cited by 51
Metadata
- Authors
- Kim, S. Y., Guevara, J. P., Kim, K. M., Choi, H. K., Heitjan, D. F., & Albert, D. A.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Pusan National University (KR)
- University of British Columbia (CA)
- University of Pennsylvania (US)
- Dartmouth–Hitchcock Medical Center (US)
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2009-06-29
- Volume
- 61
- Issue
- 7
- Pages
- 885-892
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- PMC
- PMC2714267
- OpenAlex
- W2002849282
- Cited by
- 484
- References
- 62
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 25 · 2021: 36 · 2020: 32 · 2019: 28 · 2018: 23 · 2017: 29 · 2016: 42 · 2015: 55 · 2014: 29 · 2013: 40 · 2012: 30
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arthritis Care & Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007442)
- Topics
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- hyperuricemia, serum uric acid, stroke incidence, stroke mortality, cardiovascular risk factors, hypertension, diabetes mellitus, cholesterol, sex differences
- MeSH terms
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Risk Factors, Uric Acid, Incidence, Stroke, Hyperuricemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review